Lia Diagnostics, the Philadelphia company that has developed a flushable and biodegradable home pregnancy test, raised $2.6 million in a private equity financing.
The private stock sale was disclosed in documents the company filed with the Securities and Exchange Commission. Lia is seeking to raise a total of $3 million, according to the financing. Read more
